PATENT CLAIM ANALYSIS

Application Number: 15971127
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The invention provides anti-IFNAR1 antibodies with reduced affinity for Fc receptors and/or ligands and methods of making and using such antibodies.

Claim (Index 34):
The method of  claim 33  wherein said type I interferon mediated disease is associated with the type I interferon receptor.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.1
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15711197', '13431489', '13483280', '11203251', '15714585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.740658251187017
- 35 USC 102 Novelty (BERT): 0.6247802244925799
- Combined Prediction Score: 0.7290704485175734
- Mean Citation Score: 445.23375
- Max Citation Score: 850.0428
- Similarity Product: 509.42124893188486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test